EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Time to act? Is the new era of gut hormone-based pharmacotherapy an opportunity to rethink the tier-based UK obesity care model?

Ehtasham Ahmad, Janet Jarvis, David Webb

British Journal of Diabetes · 18.12.2024 · 24 (2) · 130-135

DOI: 10.15277/bjd.2024.464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Diabetes, online erschienen am 18.12.2024. Verfasst von Ehtasham Ahmad und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity, like type 2 diabetes, is a complex, often life limiting disease influenced by genetics and modern environment. However, unlike diabetes, the provision of integrated, holistic care for people with obesity in the UK remains underdeveloped, despite the growing prevalence of obesity and increasing availability of effective treatments for weight loss. The current tier-based approach to obesity management, although based around a multidisciplinary model, can be fragmented with significant geographical variations in care. The recent approval of new pharmacotherapies by the National Institute for Health and Care Excellence offers an opportunity to rethink and reshape the approach to obesity management. This article provides a review of the current tier-based system for obesity care in UK and proposes alternative models aimed at improving efficiency, promoting equity, and enhancing person-centred outcomes.

Zitieren

APA

Ahmad, E., Jarvis, J., & Webb, D. (2024). Time to act? Is the new era of gut hormone-based pharmacotherapy an opportunity to rethink the tier-based UK obesity care model?. British Journal of Diabetes, 24(2), 130-135. https://doi.org/10.15277/bjd.2024.464

Vancouver

Ahmad E, Jarvis J, Webb D. Time to act? Is the new era of gut hormone-based pharmacotherapy an opportunity to rethink the tier-based UK obesity care model?. British Journal of Diabetes. 2024;24(2):130-135. doi:10.15277/bjd.2024.464

BibTeX
@article{Ahmad2024,
  author = {Ahmad, Ehtasham and Jarvis, Janet and Webb, David},
  title = {Time to act? Is the new era of gut hormone-based pharmacotherapy an opportunity to rethink the tier-based UK obesity care model?},
  journal = {British Journal of Diabetes},
  year = {2024},
  volume = {24},
  number = {2},
  pages = {130--135},
  doi = {10.15277/bjd.2024.464}
}
Kostenlos starten →